PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 202 filers reported holding PTC THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $23,278 | -20.1% | 572,353 | -4.8% | 0.33% | -21.4% |
Q1 2023 | $29,116 | +15.7% | 601,083 | -8.9% | 0.42% | +18.7% |
Q4 2022 | $25,175 | -99.9% | 659,540 | -9.9% | 0.36% | -29.9% |
Q3 2022 | $36,741,000 | +33.7% | 731,890 | +6.7% | 0.51% | +33.4% |
Q2 2022 | $27,477,000 | -13.2% | 685,900 | -19.2% | 0.38% | +7.9% |
Q1 2022 | $31,654,000 | -26.6% | 848,405 | -21.7% | 0.36% | -7.1% |
Q4 2021 | $43,132,000 | +2.6% | 1,082,905 | -4.2% | 0.38% | +4.1% |
Q3 2021 | $42,043,000 | -13.8% | 1,129,885 | -2.1% | 0.37% | -8.0% |
Q2 2021 | $48,770,000 | -0.7% | 1,153,785 | +11.2% | 0.40% | -5.2% |
Q1 2021 | $49,124,000 | -23.5% | 1,037,470 | -1.4% | 0.42% | -19.2% |
Q4 2020 | $64,196,000 | +18.2% | 1,051,868 | -9.4% | 0.52% | +2.6% |
Q3 2020 | $54,296,000 | +7.5% | 1,161,418 | +16.6% | 0.51% | +5.4% |
Q2 2020 | $50,522,000 | +22.0% | 995,695 | +7.3% | 0.48% | -2.4% |
Q1 2020 | $41,415,000 | +37.5% | 928,375 | +48.0% | 0.49% | +83.6% |
Q4 2019 | $30,128,000 | – | 627,270 | – | 0.27% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RTW INVESTMENTS, LP | 7,235,196 | $162,140,742 | 3.42% |
Camber Capital Management LP | 3,400,000 | $76,194 | 2.51% |
ARMISTICE CAPITAL, LLC | 6,150,000 | $137,821,500 | 2.11% |
GREAT POINT PARTNERS LLC | 500,000 | $11,205,000 | 2.04% |
COWEN AND COMPANY, LLC | 799,511 | $17,917,041 | 1.25% |
GEORGE KAISER FAMILY FOUNDATION | 45,816 | $6,491,211 | 1.22% |
SPHERA FUNDS MANAGEMENT LTD. | 218,459 | $4,895,666 | 0.89% |
SECTORAL ASSET MANAGEMENT INC | 187,016 | $4,191,029 | 0.82% |
Nebula Research & Development LLC | 21,858 | $489,838 | 0.26% |
Phocas Financial Corp. | 64,701 | $1,450,000 | 0.21% |